young people powerpoint ppt presentation
DESCRIPTION
Young peopleTRANSCRIPT
Young people <20 asking for
drug treatment in Europe in 2004
Linda Montanari, Valentina Bini, EMCDDA
2006 TDI Expert Meeting 26 September 2006 EMCDDA, Lisbon, Portugal
Structure of the presentation
• Trends 1999 -2004 among new drug clients <20 (in all treatment centres)
• Profile of young people in outpatient treatment centres in 2004
• Focus on young outpatient cannabis clients in 2004
• Limitations: • TDI use the age groups <15 and 15-19 – not more detailed breakdown• Breakdown by age is only included in some variables (by gender, first/all
clients, primary and secondary drug)• 8 countries have trend data from 1999 to 2004• 16 countries have a breakdown by age in 2004
Trend of young clients in all types of treatment
centres from 1999 to 2004 (8 countries)
Total numbers of new clients entering treatment
(all age groups) 1999 to 2004
6844067532
69412
70839
73538
76255
62000
64000
66000
68000
70000
72000
74000
76000
78000
1999 2000 2001 2002 2003 2004
Source: 2006 Stat. Bull. TDI-02 Total numbers of new clients entering treatment All Treatment centresCountries included: CZ, DK, DE, GR, IT, LV, LT, HU, MT, NL, AT, PT, SK, SI, FI, BG
New young clients entering treatment from 1999-2004 for
those countries supplying data
Source: ST.04 - 2005 REITOX National Reports All treatment centresCountries included: CZ, DK, IT, LV, MT, NL, SI, FI
0
1000
2000
3000
4000
5000
6000
7000
1999 2000 2001 2002 2003 2004
41000
42000
43000
44000
45000
46000
47000
48000
<15
15-19
Tot new clients
Profile of young clients in outpatient
treatment centres in 2004 (16 countries)
New clients entering outpatients treatment by age group in
2004 (%)
Tot new clients: 91199Source: 2006 Stat. Bull. TDI – 10 New clients entering outpatient treatment: age and primary drug at treatment in 2004 for those countries supplying data – TDI - Outpatient Treatment CentresCountries included: CZ, DK, DE, GR, IT,CY, LV, HU, MT, NL, SK, SI, FI, SE,UK, BG
1,7
15,4
25,8
20,5
15,2
10,3
5,5 5,6
0,0
5,0
10,0
15,0
20,0
25,0
30,0
<15 15-19 20-24 25-29 30-34 35-39 40-44 > 45
17,1
New clients under 15 and 15-19 years old entering outpatients
treatment in 2004 by countries (%)
Source: 2005 REITOX National Reports – TDI- Outpatient Treatment CentresCountries included: CZ, DK, DE, GR, IT,CY, LV, HU, MT, NL, SI, SK, FI, SE, UK, BG
0,0
5,0
10,0
15,0
20,0
25,0
30,0
35,0
40,0
45,0
< 15
15-19
New clients entering outpatient treatment by age group in
“new” and “old” Member States in 2004 (%)
Source: 2005 REITOX National Reports – TDI- Outpatient Treatment CentresCountries included: CZ, DK, DE, GR, IT,CY, LV, HU, MT, NL, SK, SI, FI, SE,UK,BG
0,0
5,0
10,0
15,0
20,0
25,0
30,0
35,0
40,0
<15 15-19 20-24 25-29 30-34 35-39 40-44 > 45
"Old"MemberStates (n.83813)
"New" MemberStates (n.7386)
Age distribution by primary drug among new clients in
outpatient treatment centres in 2004
Source: 2006 Stat. Bull. Fig. TDI -06 - TDI Outpatient Treatment CentresCountries included: CZ, DK, DE, GR , IT, CY, LV, HU, MT, NL, SK, SI, FI, SE, UK, BG
0% 20% 40% 60% 80% 100%
Volatile
Cannabis
Stimulants
Hallucinogens
Opiates
Cocaine
Hypnotics+sedatives
Other substances
All drugs<15
15-19
20-24
25-29
30-34
35-39
40-44
45+
New outpatient clients (all age groups) by primary drug by
country in 2004 ordered by % of primary cannabis users
Source: 2006 Stat. Bull. TDI-19 - Outpatient Treatment Centres – New clients entering outpatient treatment: distribution by primary drug at treatment in 2004 for those countries supplying dataCountries included: CZ, DK, DE, GR, IT,CY, LV, HU, MT, NL, SK, SI, FI, SE,UK,BG
0% 20% 40% 60% 80% 100%
Malta (n.147)
Bulgaria (n.442)
Greece (n.1221)
United Kingdom (n.26990)
Slovenia (n.521)
Slovakia (n.306)
Italy (n.24768)
Czech Republic (n.1056)
Total
Cyprus (n.164)
Sweden (n.829)
Netherlands (n.4785)
Denmark (n.1143)
Finland (n.447)
Germany (n.13204)
Hungary (n.4398)
Cannabis
Volatile Inhalants
Stimulants
Cocaine
Opioids
HypnoticsSedatives
Hallucinogens
Gender distribution (ratio and %) of new outpatient clients
(total new clients, clients under 15 and 15-19 years old)
Source: 2005 REITOX National Reports – TDI- Outpatient Treatment CentresCountries included: CZ, DK, DE, GR, IT,CY, LV, HU, MT, NL, SI, SK, FI, SE, UK, BGR = male to female ratio
0%
20%
40%
60%
80%
100%
total r:4,03 15-19 r:3,07 <15 r:2,33
♀ ♂
New young clients entering outpatient treatment:
age and primary drug at treatment in 2004
3,7%
1,6%
6,1%
1,7%
0,5%
8,7%
75,0%
2,8%
17,3%
5,2%
10,5%
1,1%
0,2%
1,3%
62,8%
1,6%
0,0% 10,0% 20,0% 30,0% 40,0% 50,0% 60,0% 70,0% 80,0%
Opiates
Cocaine
Stimulants
Hypnotics+sedatives
Hallucinogens
Volatile
Cannabis
Other substances
15-19; tot13263
<15; tot1548
Source: 2005 REITOX National Reports – TDI Outpatient Treatment CentresCountries included: CZ, DK, DE, GR, IT, CY, LV, HU, MT, NL, SK, SI, FI, SE, UK, BG
Focus on cannabis
Comparison of two age groups (15-16 and 17-18) for ever
in lifetime use of cannabis (%)
0
15
30
45
60
75
%
15-16 years old17-18 years old
Source: ESPAD and REITOX networkCountries included: BE, CZ, GR, ES, FR, IT, LV, HU, NL, AT, PT, SK, SE, BG
New outpatient clients entering outpatient treatment for
primary cannabis use: % of those aged <15 and 15-19
Source: 2005 REITOX National Reports – TDI Outpatient Treatment CentresCountries included: CZ, DK, DE, GR, IT,CY, HU, NL, SI, SK, FI, SE, UK, BG
0,0
10,0
20,0
30,0
40,0
50,0
60,0
70,0
80,0
< 15
15-19
Summarising…
• Total number of new clients increased from 1999 to 2004, whilst
• Number of clients under 20 stable/decrease
• In 2004 17% of drug users aged under 20 ask for drug treatment
• Young people <20 ask for treatment mainly for use of cannabis, volatile and stimulants
• Higher % of young people in the new than in the old Member States (except Finland)
• Variation between countries
• 75% of <15 and 63% of 15-19 in treatment for primary cannabis use
• There is a group of young people in treatment for opiates (17,3% of 15-19)
• Higher proportion of female clients among young clients (especially <15) than old clients
• Little correspondence between countries in the level of cannabis use in LTP and TD